Shanda Asset Management Holdings’s Charles River Laboratories CRL Stock Holding History

Shanda Asset Management Holdings’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,300	Closed	-$5.01M	–	7
2021 Q4	$5.01M	Hold	13,300	–	–	0.67%	30
2021 Q3	$5.49M	Sell	13,300 -6,544	-33%	-$2.72M	0.57%	39
2021 Q2	$7.34M	Hold	19,844	–	–	0.6%	41
2021 Q1	$5.75M	Hold	19,844	–	–	0.47%	40
2020 Q4	$4.96M	Hold	19,844	–	–	0.27%	43
2020 Q3	$4.49M	Hold	19,844	–	–	0.31%	41
2020 Q2	$3.46M	Hold	19,844	–	–	0.31%	51
2020 Q1	$2.5M	Buy	19,844 +17,637	+799%	+$2.65M	0.58%	26
2019 Q4	$337K	Hold	2,207	–	–	0.07%	31
2019 Q3	$292K	Hold	2,207	–	–	0.06%	32
2019 Q2	$313K	Hold	2,207	–	–	0.06%	31
2019 Q1	$321K	Hold	2,207	–	–	0.05%	49
2018 Q4	$250K	Buy	+2,207	New	+$276K	0.05%	46

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Shanda Asset Management Holdings's CRL Position: Q1 2022 in Review

Shanda Asset Management Holdings sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 13,300 shares — an estimated $5.01M sold.

Shanda Asset Management Holdings first reported a position in CRL in Q4 2018 and held it in 13 quarters. The position peaked at $7.34M in Q2 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

Shanda Asset Management Holdings reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
Shanda Asset Management Holdings sold 13,300 Charles River Laboratories shares in Q1 2022, an estimated $5.01M.
Shanda Asset Management Holdings first reported a position in Charles River Laboratories in Q4 2018 and held it in 13 quarters.
Shanda Asset Management Holdings's Charles River Laboratories position peaked at $7.34M in Q2 2021.
644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Shanda Asset Management Holdings's 13F filing for Q1 2022, filed 16 May 2022.